Explore 3 Stock Ideas & Industry Insights Download Free Report

Surgical Science Sweden AB

Company price
59.25 GBX 0.55 ( 0.94%)
Last update at 2026-10-27T14:44:00Z
VOLUME
188
Market Cap
0.00M
P/E
0.14

Momentum Score

…

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
59.25
Low
59.25
High
52 Week Price Range
24.02
Low
162.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
58.70
Dividend Yield
-
Revenue TTM
992.34M
Revenue Per Share
19.45
Gross Profit TTM
657.68M
Debt / Equity
-
ROE
1.47%
Net Debt
-
ROCE
-
Diluted EPS TTM
2.19

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Ebit 162.86M - 21.37M 15.18M
Other operating expenses - - - 0.67M
Income tax expense 20.20M -20.44M 4.05M 2.65M
Net income applicable to common shares 187.97M 86.25M 15.61M 12.60M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Other current liab - 93.83M 19.11M 26.99M
Common stock 2.54M 2.54M 1.73M 1.68M
Retained earnings 273.79M 85.82M -0.43M -16.04M
Other liab - 148.61M 11.63M 12.71M
Other assets 26.52M 29.56M 6.93M 7.18M
Total current liabilities 305.91M 232.38M 31.28M 39.58M
Other stockholder equity 581.13M 117.73M 0.14M -0.28M
Property plant equipment 51.36M 38.39M 8.55M 9.07M
Total current assets 826.37M 616.91M 133.39M 112.77M
Net tangible assets 491.14M 291.81M 103.65M 74.49M
Net receivables - 179.79M 32.07M 32.47M
Inventory 134.88M 113.11M 12.46M 7.19M
Accounts payable - 34.37M 2.30M 2.37M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Change to liabilities - - 0.00M 0.00M 0.00M
Total cashflows from investing activities - - -34.55M -2732.61M -8.69M
Net borrowings - - 17.09M -31.72M -5.14M
Total cash from financing activities - - 17.09M 2922.46M 4.21M
Change to operating activities - - 26.87M 31.43M -2.43M
Net income 131.65M 234.00M 187.97M 86.25M 15.61M
Change in cash - - 117.05M 229.52M 17.94M
Total cash from operating activities - - 129.49M 39.08M 23.23M
Depreciation - - - 23.90M 10.25M
Change to inventory - - -21.72M 6.46M -5.27M
Change to account receivables - - -70.76M -84.57M 1.86M
Other cashflows from financing activities - - - -84.87M 1.49M
Change to netincome - - -44.46M -33.99M -3.52M
Capital expenditures 0.00M 0.00M 9.35M 3.87M 0.40M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0AAU
Surgical Science Sweden AB
0.55
0.94%
59.25 0.14 - - -
0R15
SoftBank Group Corp.
248.00
5.84%
4494.00 - - - -
0R1E
Nintendo Co. Ltd.
-115.00
1.34%
8476.00 - - - -
0LC3
Synchrony Financial
2.34
3.20%
75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A
0.15
0.12%
122.47 0.25 - 1.18 -

Profile*

Surgical Science Sweden AB

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.

Drakegatan 7A, Gothenburg, Sweden, 412 50

46 3 17 41 65 60

313

Name Title Year Born
Mr. Gisli Hennermark Chief Exec. Officer 1972
Mr. Anders Larsson Co-Founder & CTO 1973
Ms. Anna Ahlberg Chief Financial Officer 1970
Mr. Boaz Tal ), Adv. (CPA, C.P.A. Chief Operating Officer 1968
Mr. Martin Jansson Head of Global Sales 1971
Ms. Inbal Mazor-Badichi VP of Products & Marketing 1969
Mr. Doron Zilberman VP for International Sales 1962
Mr. Daniel Evestedt Head of Devel. 1977
Mr. Jeffrey Berkley Ph.D. Chief Innovation Officer 1969
Mr. Ran Bronstein Pres of R&D 1964

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…